Drug Database
Back to search

Belgium· BE-AMP-SAM519022-00

Xermelo 250 mg

A telotristat product containing telotristat etiprate, registered in Belgium by Serb. The same ATC class is registered in 11 of our 19 countries.

ATC A16AX15

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedXermelo 250 mgATCA16AX15REGISTER NO.BE-AMP-SAM519022-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about telotristat etiprateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Telotristat is registered in 11 of 19 countries.

Countries holding a registration under ATC A16AX15 (telotristat), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose
Search telotristat products by name

Telotristat · ATC A16AX15

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Telotristat Etiprate
Manufacturer
Serb
Country
Belgium (BE)
ATC code
A16AX15
ATC class
Telotristat
Defined daily dose
0.75 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    7723646
  • be_apb
    3680154

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Telotristat in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All telotristat products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f9080455-346c-4fca-ae4e-4e58deef896d
GET /v1/drugs/f9080455-346c-4fca-ae4e-4e58deef896d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Xermelo 250 mg",
  "name_fr": "Xermelo 250 mg",
  "name_nl": "Xermelo 250 mg",
  "amp_code": "SAM519022-00",
  "strengths": [
    "250.0000",
    "250.0000",
    "250.0000",
    "168.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Telotristat Etiprate",
    "Telotristat Ethyl",
    "Lactose"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Telotristat",
  "authorisation_numbers": [
    "EU/1/17/1224/002",
    "EU/1/17/1224/001"
  ]
}
API referenceMCP serverPlans

See everything about telotristat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console